Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.640
+0.030 (1.86%)
At close: Dec 5, 2025, 4:00 PM EST
1.670
+0.030 (1.83%)
After-hours: Dec 5, 2025, 7:11 PM EST
Cibus Market Cap
Cibus has a market cap or net worth of $89.02 million as of December 5, 2025. Its market cap has decreased by -28.49% in one year.
Market Cap
89.02M
Enterprise Value
324.60M
1-Year Change
-28.49%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $288.70M to $89.02M, a decrease of -69.16%. That is a compound annual growth rate of -13.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 87.40M | 6.33% |
| Dec 31, 2024 | 82.20M | -80.39% |
| Dec 29, 2023 | 419.20M | 5,722.22% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.00M | -47.57% |
| Dec 31, 2020 | 156.40M | -32.29% |
| Dec 31, 2019 | 231.00M | -31.54% |
| Dec 31, 2018 | 337.40M | -44.70% |
| Dec 29, 2017 | 610.10M | 111.33% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |